Seroprevalence of Toxoplasmosis Infection in Diabetic Pregnant Women from Sanandaj, Kurdistan, West of Iran

DOI: https://doi.org/10.21203/rs.3.rs-29463/v1

Abstract

Background: Toxoplasma gondii is an opportunistic parasitic protozoan, which is a causative agent of serious complications such as abortion in pregnant women or fetal still birth. The aim of this study was evaluating the seroprevalence of toxoplasmosis infection in diabetic pregnant women from Sanandaj, Kurdistan, west of Iran. Methods: In this study 136 serum samples from diabetic pregnant women were collected from referred to the Toohid hospital diabetes center during June 2018 to October 2019 in Sanandaj, Kurdistan, west of Iran. IgM and IgG titers were evaluated by ELISA(enzyme-linked immunosorbent assay) method. The collected data were analyzed by SPSS 19 software and using Chi-Square and Fisher tests. Results: The ELISA method showed 35(25.7%) and 7(5.1%) of diabetic pregnant women were positive for IgG and IgM T.gondii antibodies respectively. There was statistically significant relationship between toxoplasma infection and education, gestational age and number of parity. Conclusion: The results of this study showed that public awareness and education about toxoplasmosis and its transmission routes before pregnancy may be effective in preventing congenital toxoplasmosis.

Background

Toxoplasmosis is a common parasitic disease caused by an obligate intracellular protozoan called Toxoplasma gondii, which has distributed in worldwide. Many mammals and birds act as intermediate hosts while cats are the definitive host of the parasite [1]. T. gondii has the number of different forms such as; trophozoite, oocyst and tissue cyst. The form of oocyst is created in the intestine of the definitive host and is excreted in the feces. Transmission of T. gondii is usually by undercooked and raw meat, ingestion of cysts infected and by accidental ingestion of oocysts that may contaminate soil, water, food [2] or through the placenta during pregnancy [3]. Organ transplantation and blood transfusion have also been mentioned as possible infection risk factors. This parasite can lead to chronic infection in adults, death in immunocompromised people, intrauterine fetal death, amniotic fluid disorders, spontaneous abortion during pregnancy, and hydrocephalus in congenitally infected newborns. About 20–90% of the world’s adult population in different regions is reported to have had contact with the parasite but only about 10% of infected individuals develop clinical signs and symptoms [4].The seroprevalence of T.gondii antibodies in pregnant women can vary from 6.1 to 75.2% in different societies and depending on the geographical region [5]. The prevalence rate of T. gondii in pregnant women in Portugal is 59.8% [6] in Turkey 52.1% [7] and in Southeast Asia vary, with higher seroprevalence described for Indonesia more than 60% [8] and Malaysia 49% [9]. Seropositivity of T. gondii among Iranian women was 48% -74.6% in the northern area [10], 33% − 44% in the northwest [1112], 22% -37% in the southwest [13] and 27%-54% in central parts of Iran [14]. According to WHO, diabetes is a chronic disease that occurs when body fails to produce enough insulin, or when the body cannot effectively use insulin. Gestational diabetes mellitus (GDM) is a subtype of DM and is defined as glucose intolerance with onset or first recognition during pregnancy [1516].There are serologic techniques are used to measure the level of infection to toxoplasmosis in humans and animals. Among these methods, the most common techniques are ELISA which is a standard method for examining anti-T. gondii antibodies. This method is widely available, easy to perform and has high sensitivity and specificity [17].

The aim of this study was to determine the IgG and IgM antibodies created against T. gondii infections using the ELISA method in diabetic pregnant women in Sanandaj, Kurdistan, west of Iran.

Methods

In this study totally 136 blood samples were collected from diabetic pregnant women referred to the Toohid hospital diabetes center during the period of June 2018 to October 2019 in Sanandaj, Kurdistan, west of Iran. Five mL of blood was taken from each person. Then, samples were centrifuged at 3000 rpm for 10 minutes. The sera were separated and kept at -20 ºC until the assay. All subjects completed a questionnaire including demographic information and risk factors.

Questionnaire

The applied questionnaire anchored in demographic data including age, education, occupation, and residence was prepared before the collection of blood samples. Moreover, possible risk factors, such as contact to animals, cats, and soil, consumption of half-cooked, cooked and frosty meat, blood transfusion, gestational age, history of abortion, use of well and pipe water, Residence area and the number of parity were evaluated in diabetic pregnant women.

ELISA Test

In this study the anti-T. gondii antibodies were evaluated. All the serum samples were tested using the commercially available ELISA kit (Pishtaz Teb Co, Iran). Analyses were performed following the manufacturer's instructions. Based on the ELISA kit, If IgG and IgM antibodies concentration was > 1.1 were defined as positive results, and < 0.9 were defined as negative results.

Statistical analysis

Data were analyzed using SPSS software (version 19). The Chi-square and Fisher tests were used to compare the seroprevalence values, related to the characteristics of the subjects. P ≤ 0.05 was considered as the level of significance.

Results

A total of 136 diabetic pregnant women of age ranging from 17 to 40 years had participated in this study and the mean age was 32.89. A total of 136 samples, 35 (25.7%) and 7(5.1%) were positive for IgG and IgM antibodies respectively. The results of this study revealed significant statistical differences among risk factors such as; level of education (P = 0.02), gestational age (P = 0.008) and number of parity (P = 0.007) with Toxoplasma IgG seroprevalence rate in diabetic pregnant women. No significant correlation was found between age and IgG seropositivity anti-T. gondi, but more half (74.3%) of the study participants were in the age range > 30 years. All of them were housewives in occupation. The prevalence rate showed no significant differences between women resident with Toxoplasma infection in rural and those in urban and margin areas, but the rate of infection was higher in rural patients than others areas. We did not find significant relationship between diabetic pregnant women and occupation, meat consumption, blood transfusion, History of abortion, contact to cats, animals and soil, and use of water with anti-Toxoplasma antibodies. The data of the above variables are summarized in Table 1.We found no statistically significant relationship between all characteristics and risk factors with the IgM T. gondii antibody (Data not shown).

Table 1

The Frequency Distribution of Specific anti-Toxoplasma IgG in diabetic pregnant women in Sanandaj, West of Iran

   

SeropositivityN %

Seronegativity %N

P value

Age groups (yr)

<=20

0

2(2)

0.495

21–30 years

9(25.7)

33(33.7)

> 30 years

26(74.3)

66(65.3)

Education

Illitrature

5(14.3)

8(7.9)

0.02∗

elementary

14(40.0)

17(16.8)

school

2(5.7)

20(19.8)

Diploma

8(22.9)

34(33.7)

University

6 (17.1)

22(21.8)

Occupation

Housewife

35(100)

101(100)

 

Employ

0(0)

0(0)

Meat

forsty

4(11.4)

13(12.9)

0.75

Half cooked

0

3(3)

cooked

30(85.7)

83(83.2)

raw

1(2.9)

2(2)

Gestational age

1st trimester4119

3 (8.6)

28(27.7)

0.008∗

2nd trimester

17(48.5)

24(23.8)

Third trimester

15(42.9)

49(48.5)

Residence area

Urban

6(17.1)

10(10)

0.168

Rural

23(65.8)

82(82.1)

Margin

6(17.1)

9(8.9)

History of abortion

Yes

11(31.4)

28(27.7)

0. 676

No

24(68.6)

73(72.2)

Contact Cat

Yes

1(2.9)

1(1.0)

0.429

No

34(97.1)

100(99)

Contact soil

Yes

13(37.1)

23(23)

0.103

No

22(62.9)

77(77)

Contact animal

Yes

8(22.9)

11(10.9)

0.07

No

27(77.1)

90(89.1)

Infusion Blood

Yes

2(5.7)

4(4)

0.663

No

33(94.3)

97(96)

Use of water

Tap

33(94.3)

95(94.1)

.0.961

well

2(5.7)

6(5.9)

N. Parity

0–2

28(80.0)

96(95)

0.007∗

≥ 3

7(20.0)

5(5)

∗ Statistically significant at P < 0.05

Discussion

This study is the first study to survey the status of T. gondii antibodies in diabetic pregnant women in this region. In our study, the seroprevalence of IgG T.gondii antibody in diabetic pregnant women was 25.7% which was lower than the studies by Khattab et al (45%) in Egypt in 2019 [18], Yentur et al (53%) in turkey in 2015[19] and Mohammadi et al (28%) in Iran in 2008 [20], but higher than (16.5%) as reported by Li et al in China in 2018 [21], and much higher than (5.4%) by Krause et al in 2009 [22]. In addition, our study showed that the prevalence rate of IgM T.gondii antibody in diabetic pregnant women was 5.1% which was agreement by Silva et al (5.3%) in 2015 [23], and higher than a study by Saki et al (2.7%) in 2016 [15] but it was lower than in comparison with the studies by Alghamdi et al (6.4%) in Saudi Arabia in 2015 [24] and Tammam et al (18.4%) in Egypt in 2103 [25]. The results of present study indicated that the prevalence of the IgG toxoplasma antibody in pregnant women in Sanandaj was lower than in other parts of Iran [15, 20]. This may be due to the cold climate of this area and this temperature is not suitable for the sporulation of toxoplasma oocysts. Toxoplasma infection’s geographical distribution is related to several environmental factors such as food habits, variations in climate, and contact with infected cat feces [26]. In the north of Iran (around the Caspian Sea), there is a high prevalence of T. gondii infection, whereas, in hot provinces and cold mountainous, lower seropositivity rates are found [27]. In this research negative seroprevalence of T. gondii IgG and IgM were 74.3% and 94.9% in diabetic pregnant women respectively. Many studies have shown that about 75% of the world's women are serologically negative for this parasite and therefore the risk of acute toxoplasmosis and its transmission to women during pregnancy are likely [28].The present study showed no apparent relationship between Toxoplasma infection and age (P = 0.495) but the percentage of IgG seroprevalence was higher in ≥ 30 years old (74.3%) which is agreement with other previous similar studies [2930].It can be explained that these women have been exposed to the risk factors than other women for a longer period of time [31]. In our study we did not find significant relationship between the seroprevalence of T. gondii infection and the residence areas (P = 0.168) which is in accordance with other reports [11, 32], although it was demonstrated in other studies that living in rural areas had a higher risk of toxoplasmosis than those in urban areas [3334]. In this study, we found a significant relationship between T. gondii infection and the level of education (P = 0.02). There are similar reports in Iran [35, 11].In some of the studies, the low level of education was associated with a higher rate of toxoplasmosis. Lack of effective information about this disease such as the route of transmission during pregnancy and poor socioeconomic status can increase the risk of infection [3637]. The history of contact with cats is often mentioned as a risk factor in pregnant women for T. gondii infection [39]. Our findings did not show significant association between T. gondii infections and contact to cats (P = 0.429) which is accordance with other studies [28, 38]. Moreover, the prevalence of the parasite among domestic cats may depend on the type of cats in different countries. The findings did not reveal a meaningful relationship between the consumption of half-cooked meats or frosty and infection, too, which is line with the study from Turkey [40] but is contrast by previous studies has been conducted in Cameroon and Japan [4142].This variation could be due to differences in the prevalence of the parasite in the animals in those countries as well as the type of animals consumed. The current study showed there was association between gestational age and IgG T.gondi, antibody (P = 0.008).The rate of IgG in the second trimester of pregnancy was more prevalent (48.5%) than its similar subgroups which are similar to other studies [15, 42]. If the mother is infected with T. gondii during the second and third trimester of pregnancy, the probability of prenatal transmission will be increased to 80%.

There was a significant relationship between toxoplasmosis and the number of parity in this study which according to similar previous studies (P = 0.007) (43).

Contaminated drinking water is also a potential source of T. gondii infection. In the present study, there was no association between the source of water for drinking and Toxoplasma infection which is consistent with other studies [35, 40]. In the current research similar to the results of previous studies [36, 44], no significant relationship was found between the seroprevalence of T. gondii infection and the history of abortion in diabetic pregnant women, in contrast, there were reports in Iraq and China [4546]. In addition in our study although the rate of IgG and IgM T.gondii antibodies in contact to animals and soil in diabetic pregnant women were relatively high, we did not observed significant relation between toxoplasmosis and these risk factors which is agreement with studies conducted in China and Italy [4748]. No significant association between blood transfusion and occupation with toxoplasma infection was observed.

Conclusion

In present study, level of education, number of parity and gestational age in diabetic pregnant women were risk factors for T. gondii positivity. Therefore, require awareness on the disease and its transmission, designing the preventive measures and care to avoid parasite exposure during their pregnancies. Also screening tests for toxoplasmosis periodically should be done.

Abbreviations

T. gondii: Toxoplasma gondii, ELISA: enzyme-linked immunosorbent assay, GDM: Gestational diabetes mellitus, DM: diabetes mellitus, WHO: World Health Organization

Declarations

Acknowledgements: Authors are grateful the Research Deputy of Kurdistan University of Medical Sciences, Sanandaj, Iran for the financial supports the current research.

Authors’ contributions: NB: supervised data management, Preparation of materials and tools, interpretation of the data and drafted the manuscript, NSH and FF designed the protocol and collected of samples, MZ: revise the manuscript and edited. The authors read and approved the final manuscript.

Funding: This study was funded through Research Deputy of Kurdistan University of Medical Sciences, Sanandaj, Iran.

Availability of data and materials: All data generated and analyzed during the current study are available from the corresponding author on a reasonable request.

Ethics approval and consent to participate: The current research approved in ethical committee of Kurdistan University of Medical Sciences, Sanandaj, Iran with Grant No: 1397/156

Consent for publication: applicable

Competing interests: The authors declare that they have no competing interests.

Author details: 1 Specialist Diabetes Clinic. Toohid Hospital, Kurdistan University of Medical Sciences, 2 Department of Obstetrics and Gynecology, School of Medicine Social, Determinants of Health Research Center ,Research Institute for Health Development Beasat Hospital Kurdistan University of Medical Sciences,3 Zoonoses Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran,4 Department of Health in Emergencies and Disaster, School of Public Health, Tehran University of Medical Sciences Tehran, Iran

References

  1. Jones J L, Kruszon-Moran D, Wilson M, McQuillan G, Navin T J, McAuley B. “Toxoplasma gondii infection in the United States: seroprevalence and risk factors,” American J Epidemiol.200l; 154(4): 357–365.
  2. Dubey J. P, Hill D. E, Jones J. L. “Prevalence of viable Toxoplasma gondii in beef, chicken, and pork from retail meat stores in the United States: risk assessment to consumers,” J Parasitol, 2005; (91) 5: 1082–1093.
  3. Elsheikha M, “Congenital toxoplasmosis: priorities for further health promotion action,” Public Health, 2008; 122: 4: 335–353.
  4. Ayi I, Edu SAA, Apea-kubi KA, Boamah D, Bosompem KM, Edoh D. Toxoplasmosis in pregnant women in Ghana. Gh Med J. 2009; 43(3):107-114.
  5. Robert-Gangneux F, Darde ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012; 25(2):264–296.
  6. Varella IS, Wagner MB, Darela AC, Nunes LM, Muller RW .Seroprevalence of toxoplasmosis in pregnant women. J Pediatr.2003; 79(1):69–74.
  7. Ocak S, Zeteroglu S, Ozer C, Dolapcioglu K, Gungoren A. Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in southern Turkey. Scand J Infect Dis. 2007; 39(3):231–234.
  8. Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int JParasitol. 2009; 39: 1385–1394.
  9. Nissapatorn V, Noor Azmi MA, Cho SM, Fong MY, Init I, Rohela M. Toxoplasmosis: prevalence and risk factors. J Obstet Gynaecol.2003; 23: 618–624.
  10. Saeedi M, Veghari GR, Marjani A. Seroepidemiologic evaluation of anti-Toxoplasma antibodies among women in north of Iran. Pak J Biol Sci. 2007; (10): 2359- 62.
  11. Hashemi HJ, Saraei M. Seroprevalence of Toxoplasma gondii in unmarried women in Qazvin Islamic Republic of Iran. East Mediterr Health J. 2010; 16(1): 24-8.
  12. Abdi J, Shojaee S, Mirzaee A, Keshavarz  H. Seroprevalence of Toxoplasmosis in Pregnant Women in Ilam Province Iran. Iranian J Parasitol.2008; 3(2): 34-7.
  13. Fouladvand M, Barazesh A, Naeimi B, Zandi K, Tajbakhsh S. Seroprevalence of toxoplasmosis in high school girls in Bushehr city South-west of Iran 2009. Afr J Microbiol Res.2010; 4 (11): 1117-21.
  14. Manouchehri Naeini K, Deris F, Zebardast N. The immunity status of the rural pregnant women in Chaharmahal and Bakhtyari province against Toxoplasma infection 2001–2002. J Shahrekord Med Sci. 2004; 6(3):63–72.
  15. Saki J, Shafieenia S, Foroutan-Rad M. Seroprevalence of toxoplasmosis in diabetic pregnant women in southwestern of Iran. J Parasit Dis. 2016; 40(4):1586–1589.
  16. Shirbazou S , Delpisheh A , Mokhetari R , Tavakoli G. Serologic Detection of Anti T. gondii Infection in Diabetic Patients. Iran Red Crescent Med J. 2013; 15(8): 701-703.
  17. Robert-Gangneux F, Darde ML. Epidemiology of and diagnostic strategies toxoplasmosis. Clin Microbiol Rev. 2012; 25(2):264–296.
  18. Khattab Hala M., Safeya O. El Bassiouni, Manal H. Abuele, Dalia O. Seroprevalence of Toxoplasma gondii among a group of Egyptian patients with type I diabetes mellitus. Bulletin of the National Research Centre. 2019; 43:20.2-7.
  19. Yentur DN, Simsek Z, Gurses G, et al. Prevalence and associated risk factors of Toxoplasma gondii in female farm workers of southeastern Turkey. J Infect Dev Ctries. 2015; 9(01):087–93.
  20. Mohammadi P, Taherpoor A, Mohammadi H. Seroepidemiology of toxoplasmosis among women referring to pre-marriage consulting centers in Sanandaj province in 2006. Iran J Infect Dis Trop Med. 2008; 40(1):5.
  21. Li YX, Xin H, Zhang X, Wei C, Duan Y, Wang H, Niu H. Toxoplasma gondii infection in diabetes mellitus patients in China: Seroprevalence, risk factors, and case-control studies. BioMed Res Int. 2018:1–9.
  22. 22. Krause I, Anaya JM, Fraser A, Barzilai O, Ram M, Abad V, etal. Anti-infectious antibodies and autoimmune-associated auto antibodies in patients with type I diabetes mellitus and their close family members. Ann N Y Acad Sci. 2009; (1173):633–639.
  23. Silva M G, Vinaud M C, Castro A M. Prevalence of toxoplasmosis in pregnant women and vertical transmission of Toxoplasma gondii in patients from basic units of health from Gurupi, Tocantins, Brazil, from 2012 to 2014. PLoS ONE.2015; 10(11): e0141700.
  24. Alghamdi J, Elamin MH, Alhabib S. Prevalence and genotyping of Toxoplasma gondii among Saudi pregnant women in Saudi Arabia. Saudi Pharm J. 2016; 24(6):645-51.
  25. Tammam AE, Haridy MA, Abdellah AH, Ahmed SR, Fayed HM, Alsammani MA. Seroepidemiology of toxoplasma gondii infection in women with first trimester spontaneous miscarriage in qena governorate, Egypt. J Clin Diagn Res. 2013; 7(12):2870-3.
  26. Galvan Ramirez MDLL, Troyo R, Roman S. A systematic review and Meta -analysis of Toxoplasma gondii infection among the Mexican population. Parasit Vectors. 2012; 5:271.
  27. Sharif M, Sarvi S, Shokri  A. Toxoplasma gondii infection among sheep and goats in Iran: a systematic review and meta-analysis. Parasitol Res. 2015; 114:1–16.
  28. Altintas N, Kuman HA, Akisu C, Aksoy U, Atambay M. Toxoplasmosis in last four years in Agean region. Turkey J Egypt Soc Parasitol. 1997; 27(2):439-43.
  29. Shin DW , Cha DY, Hua Q J , Cha G H , Lee YH .Seroprevalence of Toxoplasma gondii Infection and Characteristics of Seropositive Patients in General Hospitals in Daejeon, Korea. Korean J Parasitol. 2009; 47(2): 125–130.
  30. Nijem K, Al-Amleh S: Seroprevalence and associated risk factors of toxoplasmosis in pregnant women in Hebron district, East Mediterr Health J. 2009, 15:1279–1284.
  31. Remington J.S. Toxoplasmosis in the adult. Bull N Y Acad Med 1974; 50: 211-227.
  32. Hamidi. M H, Shahat A, Bayoumy A, Khairy M, Shady H. Toxoplasmosis prevalence in Egyptian diabetic patients. Al-Azhar Assiut Med J.2018; 16(2):113-116.
  33. Fallahi Sh, Badparva E, Mohammadi M, Ebrahimzadeh F, Pournia Y. Ser-oepidemiological Study of Toxoplasma gondii in Women Referred to Khorramabad Lab-oratory of Health Center for Medical Examination before Marriage, Lorestan Province, Iran, 2007. Asian J Biol Sci.2009; 2 (3): 88-94.
  34. Ades AE, Parker S, Gilbert R, Tookey PA, Berry T, Hjelm M, et al. Maternal prevalence of Toxoplasma antibody based on anonymous neonatal serosurvey: a geographical analysis. Epidemiol Infect. 1993; 110(1): 127-33.
  35. Mostafavia SN, Ataei B, Nokhodian Z, Yaran  M, Babak  Seroepidemiology of Toxoplasma gondii infection in Isfahan province, central Iran: A population based study. J Res Med Sci.2011; 16 (4): 496-501.
  36. Ataeian A, Tadayon P. Prevalence of Toxoplasma gondii antibodies in women of Zanjan Hakim Hidajy hospital. J Zanjan Med Sci.2000; 8(32):4-11.
  37. Jones JL, Kruszon-Moran D, Wilson M, Mcquillan G, Navin T, Mcauley JB. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol.2001; 154(4): 357-65.
  38. Ishaku B, Ajogi I, Umoh J, Lawal I, Randawa A: Seroprevalence and risk factors for Toxoplasma gondii infection among antenatal women in Zaria, Nigeria. Res J Medicine & Med Sci 2009; 4:483–488.
  39. Zemene E,  Yewhalaw D, Abera S , Belay T, Samuel A .Seroprevalence of Toxoplasma gondii and associated risk factors among pregnant women in Jimma town, Southwestern Ethiopia . BMC Infect Dis 2012, (12) 337:2-6.
  40. Ertug S, Okyay P, TurkmenM, Yuksel H. Seroprevalence and risk factors for toxoplasma infection among pregnant women in Aydin province, Turkey. BMC Public Health. 2005; 5: 66-71.
  41. Wam EC, Sama LF, Ali IM, Ebile WA, Aghangu LA, Tume CB. Seroprevalence of Toxoplasma gondii IgG and IgM antibodies and associated risk factors in women of child-bearing age in Njinikom, NW Cameroon. BMC Res Notes. 2016; 9:406.
  42. Sakikawa M, Noda S, Hanaoka M, Nakayama H, Hojo S, Kakinoki S, et al. Anti-Toxoplasma antibody prevalence, primary infection rate, and risk factors in a study of toxoplasmosis in 4,466 pregnant women in Japan. Clin Vaccine Immunol. 2012; 19(3):365–367.
  43. Khademi Z, Ghaffarifar F, Dalimi A, Davoodian P, Abdolia. Prevalence and Risk Factors of Toxoplasma gondii Infection among Pregnant Women in Hormozgan Province, South of Iran. Iran J Parasitol, 2019; 14(1):167-173.
  44. Sadooghian S, Mahmoudvand H, Mohammadi M A, Nazari N et al. Prevalence of Toxoplasma gondii Infection among Healthy Blood Donors in Northeast of Iran.  Iran J Parasitol.2017:554-562.
  45. Hamad N.R, Kadir MA. Prevalence and comparison between the efficacies of different techniques for diagnosis of Toxoplasma gondii among women in Erbil province Iraqi-Kurdistan. Annual International Interdisciplinary Conference.2013:24-26 April, Azores, Portugal, (Abstract).
  46. Li X., Wei H., Zhang H., Peng H., Lindsay D.S. A Meta-Analysis on risks of adverse pregnancy outcomes in Toxoplasma gondii infection. Plos One. 2014; 9(5): 112.
  47. Tawfiq, S K. Some immunological aspects of toxoplasmosis in pregnant and repeated aborted women. M. Sc. Thesis, College of Medicine, University of Tikrit. 2013; 138.
  48. Puccio G., Cajozzo C., Canduscio L.A.,Cino, L., Romano A., Schimmenti M.G, et al. Epidemiology of Toxoplasma and CMV serology and of GBS colonization in pregnancy and neonatal outcome in a Sicilian population. Ital J Pediatric. 2014; 40(23):1-8.